These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 14655487

  • 21. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul 27; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genetic determinants of response to statins.
    Peters BJ, Klungel OH, de Boer A, Maitland-van der Zee AH.
    Expert Rev Cardiovasc Ther; 2009 Aug 27; 7(8):977-83. PubMed ID: 19673675
    [Abstract] [Full Text] [Related]

  • 28. The power of statins: aggressive lipid lowering.
    Jones PH.
    Postgrad Med; 2002 Oct 27; 112(4 Suppl):23-30. PubMed ID: 19667597
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [HMA CoA reductase inhibitors].
    Kostner GM.
    Wien Med Wochenschr; 1999 Oct 27; 149(5-6):109-10. PubMed ID: 10408000
    [No Abstract] [Full Text] [Related]

  • 31. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].
    Einecke D.
    MMW Fortschr Med; 2004 Mar 25; 146(13):4-5. PubMed ID: 15219114
    [No Abstract] [Full Text] [Related]

  • 32. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS, Bissonnette S, Habib R, Boukas S, Ezetrol Add-On Investigators.
    Ann Pharmacother; 2007 Sep 25; 41(9):1345-51. PubMed ID: 17666579
    [Abstract] [Full Text] [Related]

  • 33. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046
    [Abstract] [Full Text] [Related]

  • 34. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    Arterioscler Thromb Vasc Biol; 2004 Aug 04; 24(8):e149-61. PubMed ID: 15297292
    [Abstract] [Full Text] [Related]

  • 35. Lipid disturbances in chronic renal failure--patomechanisms and treatment.
    Rutkowski B, Chmielewski M.
    Rocz Akad Med Bialymst; 2004 Aug 04; 49():139-44. PubMed ID: 15631330
    [Abstract] [Full Text] [Related]

  • 36. [Therapy of dyslipidemia in post-infarction: state of the art].
    Borgia MC, Nardi M, Da Ros S, Castellano V.
    Clin Ter; 2007 Aug 04; 158(6):523-32. PubMed ID: 18265719
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.